Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Tumor Hypoxia of Head-and-Neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Natural history/Epidemiology, Treatment
Active
18 to 70
Other
HNO-FMISO-FU
NCT00180180
Last Modified:
4/24/2008
 
First Published:
11/12/2007
2.
Phase II Study of Positron Emission Tomography Using Fluoromisonidazole F 18 and Fludeoxyglucose F 18 in Assessing Tumor Hypoxia in Patients Undergoing Therapy for Newly Diagnosed Stage III or IV Cervical Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Diagnostic, Treatment
Active
18 and over
NCI
UW-6143
UW IRB# 6143, 7958, NCT00559377
3.
Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Diagnostic
Active
18 and over
Other
07-151
NCT00574353
4.
Validation of 18F-MISO-PET and 18F-FLT-PET
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Diagnostic, Treatment
Active
Over 18
Other
100
NCT00159978
5.
Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
18 and over
Other
04-070
NCT00606294
6.
Hypoxia-Positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic, Treatment
Active
18 and over
Other
07-162
NCT00713037
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute